Teradyne Inc. Stock Falls 10.6%, Underperforms Peers
Dow Jones2026/10/22 20:33This article was automatically generated by Dow Jones using technology from Automated Insights.
Shares of Teradyne Inc. tumbled 10.6% to $308.75 on what proved to be an all-around grim trading session for the stock market, with the Dow Jones Industrial Average remaining mostly unchanged at 52,867.98 and the S&P 500 Index falling 1.2% to 7,663.43.
The stock's fall snapped a three-day winning streak.
Teradyne Inc. closed 36.7% below its 52-week high of $487.91, which the company achieved on June 30th.
The stock demonstrated a mixed performance when compared to some of its peers, as Keysight Technologies Inc. fell 8.7% to $311.52, Fortive Corp. rose 2.4% to $60.05, and Cohu Inc. fell 16.33% to $46.26.
Trading volume totaled 5.8 million, compared to the 50-day average of 2.5 million.
Data source: Dow Jones Market Data, FactSet
(END) Dow Jones Newswires
October 22, 2026 16:33 ET (20:33 GMT)
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
South Korea’s current account surplus in September exceeded 60 billions USD for the first time, with semiconductor exports becoming the main driver
Driven by booming semiconductor exports, South Korea's current account surplus in September surged to a record high.
CoreWeave (CRWV.US) bonds hit a new low as changes in Texas data center policies impact AI cloud trading
CoreWeave (CRWV.US) bonds fell sharply on Wednesday, with some dropping to new lows.
AstraZeneca (AZN.US) reportedly receives a $10 billion acquisition offer! Shares of obesity drug developer Rhythm (RYTM.US) soar in response
According to three people familiar with the matter, AstraZeneca previously proposed to acquire obesity drug developer Rhythm Pharmaceuticals for approximately 10 billion dollars.
Goldman Sachs and Apollo in Talks to Sell 40 Billion-Dollar AI Chip Financing for SpaceX (SPCX.US), Market's Willingness to Take Over Faces Test
Goldman Sachs (GS.US) and Apollo Global Management (APO.US) are in talks with Wall Street investors to begin selling portions of a roughly $40 billion chip financing deal for SpaceX (SPCX.US).
Crypto prices
More
